Author/Authors :
Amiri, Rezvan Department of Dermatology - Afzalipour Hospital - Afzalipour Faculty of Medicine - Kerman University of Medical Sciences, Kerman, Iran , Omidvand, Ziba Department of Dermatology - Afzalipour Hospital - Afzalipour Faculty of Medicine - Kerman University of Medical Sciences, Kerman, Iran , Mohammadi, Saman Department of Dermatology - Afzalipour Hospital - Afzalipour Faculty of Medicine - Kerman University of Medical Sciences, Kerman, Iran , Khalili, Maryam Department of Dermatology - Afzalipour Hospital - Afzalipour Faculty of Medicine - Kerman University of Medical Sciences, Kerman, Iran , Aflatoonian, Mahin Department of Dermatology - Afzalipour Hospital - Afzalipour Faculty of Medicine - Kerman University of Medical Sciences, Kerman, Iran
Abstract :
Background: Pityriasis versicolor is a recurrent non-inflammatory superficial fungal infection. Application of antifungal shampoo is a simple treatment modality for pityriasis versicolor that can be
used on an extensive surface area. Currently, there is no study to evaluate the efficacy of climbazole shampoo. In this study,
the efficacy of 2% ketoconazole shampoo was compared to 2%
climbazole shampoo in the dermatologic clinic of Afzalipour
Hospital, Kerman, Iran.
Methods: This triple-blind randomized clinical trial was performed
on 60 patients diagnosed with pityriasis versicolor. Participants
were categorized into groups A (ketoconazole shampoo) and
B (climbazole shampoo) based on simple randomization. KOH
smear was achieved from all participants at the baseline, four
weeks after commencing treatment, and at three months follow–
up. Participants were instructed to apply shampoo three times
a week for three weeks on all body surfaces and scalp for 10
minutes before rinsing. Evaluation of treatment was based on
clinical improvement and results of KOH smears. Complete
cure was defined as negative KOH smear and complete clinical
improvement.
Results: Seventy percent of the patients in the ketoconazole group
and 43.3% of the patients in the climbazole group had negative
smears four weeks after commencing treatment (P = 0.037).
Complete clinical improvement at the three-month follow-up
was 26.7% and 13.3% in the ketoconazole and climbazole groups,
respectively (P = 0.402).
Conclusion: In the present study, 2% ketoconazole shampoo
had significantly greater efficacy in terms of mycological cure than climbazole shampoo among pityriasis versicolor patients.